Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection.

Petrara MR, Freguja R, Gianesin K, Zanchetta M, De Rossi A.

Front Microbiol. 2013 Oct 18;4:311. doi: 10.3389/fmicb.2013.00311. eCollection 2013. Review.

3.
4.

Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.

Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W.

J Med Virol. 2001 Sep;65(1):114-20.

PMID:
11505452
5.

Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.

Gorres KL, Daigle D, Mohanram S, McInerney GE, Lyons DE, Miller G.

MBio. 2016 Mar 1;7(2):e00113. doi: 10.1128/mBio.00113-16.

6.

Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders.

Dolcetti R, Di Luca D, Carbone A, Mirandola P, De Vita S, Vaccher E, Sighinolfi L, Gloghini A, Tirelli U, Cassai E, Boiocchi M.

J Med Virol. 1996 Apr;48(4):344-53.

PMID:
8699167
8.

Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment.

Petrara MR, Giunco S, Serraino D, Dolcetti R, De Rossi A.

Cancer Lett. 2015 Dec 1;369(1):37-44. doi: 10.1016/j.canlet.2015.08.007. Epub 2015 Aug 13. Review.

9.

Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.

Petrara MR, Cattelan AM, Zanchetta M, Sasset L, Freguja R, Gianesin K, Cecchetto MG, Carmona F, De Rossi A.

J Clin Virol. 2012 Mar;53(3):195-200. doi: 10.1016/j.jcv.2011.12.013. Epub 2011 Dec 30.

PMID:
22209290
10.

Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells.

Hau PM, Deng W, Jia L, Yang J, Tsurumi T, Chiang AK, Huen MS, Tsao SW.

J Virol. 2015 Jan;89(1):652-68. doi: 10.1128/JVI.01437-14. Epub 2014 Oct 29.

11.

Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.

Leong IT, Fernandes BJ, Mock D.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):184-93.

PMID:
11505266
12.

Microenvironmental abnormalities induced by viral cooperation: Impact on lymphomagenesis.

De Paoli P, Carbone A.

Semin Cancer Biol. 2015 Oct;34:70-80. doi: 10.1016/j.semcancer.2015.03.009. Epub 2015 Mar 30. Review.

13.

Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection.

Legoff J, Amiel C, Calisonni O, Fromentin D, Rajoely B, Abuaf N, Tartour E, Rozenbaum W, BĂ©lec L, Nicolas JC.

J Clin Immunol. 2004 Mar;24(2):125-34.

PMID:
15024179
14.

Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus.

Siebert JD, Ambinder RF, Napoli VM, Quintanilla-Martinez L, Banks PM, Gulley ML.

Hum Pathol. 1995 Nov;26(11):1191-5.

PMID:
7590691
15.

EBV Chronic Infections.

Eligio P, Delia R, Valeria G.

Mediterr J Hematol Infect Dis. 2010 Aug 10;2(1):e2010022. doi: 10.4084/MJHID.2010.022.

16.

Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection.

Pinzone MR, Berretta M, Cacopardo B, Nunnari G.

Semin Oncol. 2015 Apr;42(2):258-71. doi: 10.1053/j.seminoncol.2014.12.026. Epub 2014 Dec 31. Review.

PMID:
25843730
18.

Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.

Reusch JA, Nawandar DM, Wright KL, Kenney SC, Mertz JE.

J Virol. 2015 Feb;89(3):1731-43. doi: 10.1128/JVI.02781-14. Epub 2014 Nov 19.

19.

Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda.

Petrara MR, Penazzato M, Massavon W, Nabachwa S, Nannyonga M, Mazza A, Gianesin K, Del Bianco P, Lundin R, Sumpter C, Zanchetta M, Giaquinto C, De Rossi A.

J Infect Dis. 2014 Aug 1;210(3):392-9. doi: 10.1093/infdis/jiu099. Epub 2014 Feb 18.

PMID:
24550442
20.

Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.

Whitehurst CB, Li G, Montgomery SA, Montgomery ND, Su L, Pagano JS.

MBio. 2015 Oct 20;6(5):e01574-15. doi: 10.1128/mBio.01574-15.

Supplemental Content

Support Center